Dark

KALV
KalVista Pharmaceuticals, Inc. Common Stock
stock NASDAQ

At Close

Oct 24, 2025 3:59:59 PM EDT

11.11USD+1.137%(+0.12)1,223,595

0.00Bid 0.00Ask 0.00Spread

Pre-market

Oct 24, 2025 8:43:30 AM EDT

10.90USD-0.819%(-0.09)1,783

After-hours

Oct 24, 2025 4:04:30 PM EDT

11.10USD-0.135%(-0.01)4,320

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

561.57M

CEO

Thomas Crockett

Headquarters

Cambridge, Massachusetts, USA

Industry

Biotechnology

Next Earnings

Dec 4, 2025 (38d)

Last Split

Nov 22, 20161for14reverse

XENT EYEG KOOL SNOA XLV

KALV Stats

Avg. Vol. 10 Day

979,798

Avg. Vol. 30 Day

1,270,699

Employees

Market Cap

561,566,191

Shares Out.

50,523,274

On/Off Exchange

57%/43%

6 Month Beta

0.64

1 Year Beta

0.76

2 Year Beta

0.84

3 Year Beta

0.89

52 Week Low

7.30

52 Week High

17.28

SMA50

12.82

SMA200

12.12

1 Week

-3.60%

1 Month

-10.36%

3 Month

-23.77%

6 Month

-14.43%

1 Year

-4.84%

2 Year

+38.08%

5 Year

-27.35%

Profile

kalvista is a clinical stage pharmaceuticals company focused on the discovery, development, and commercialization of small molecule protease inhibitors.

KALV Stock Summary

KalVista Pharmaceuticals, Inc. Common Stock (NASDAQ:KALV) stock price today is $11.11, and today's volume is 1,223,595. KALV is up 1.137% today. The 30 day average volume is 1,270,699. KALV market cap is 561.57M with 50,523,274 shares outstanding.